Boditech Med, Inc. · KRX:206640

Boditech Med, Inc. financial statements

Boditech Med, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue162.1B138.2B134.2B118.1B157.7B144.1B72.8B66.2B52.6B55.0B
Cost of revenue66.1B56.4B53.3B47.2B59.3B46.5B31.8B33.1B23.1B20.5B
Gross profit96.0B81.8B80.9B70.8B98.4B97.7B41.0B33.1B29.5B34.5B
Research and development18.6B16.0B13.4B14.7B14.3B11.6B8.88B9.10B9.93B7.60B
Selling, general and administrative20.2B35.3B34.8B28.1B29.8B18.1B15.6B16.4B15.9B13.5B
Operating income28.9B26.0B28.8B24.7B51.9B63.6B14.8B-437.8M-1.11B12.5B
Depreciation and amortization10.1B7.62B8.23B7.47B6.04B5.39B5.08B4.14B3.63B1.83B
EBITDA39.0B33.6B37.0B32.1B57.9B69.0B19.9B3.70B2.52B14.3B
Interest expense411.3M352.5M350.4M203.9M196.5M466.7M1.52B000
Income before tax27.8B32.4B31.6B27.0B56.0B60.2B13.1B-1.79B-2.96B13.8B
Income tax1.68B8.64B11.9B1.18B680.8M181.7M1.53B
Net income23.7B27.3B25.9B24.2B44.4B45.5B11.6B-1.69B-2.15B12.6B
Earnings per share, basic1,089.601,240.441,181.071,099.411,963.921,974.14508.45-73.07-93.29547.95

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents19.6B47.9B42.5B2.50M2.75M24.0B20.7B25.7B22.8B13.0B
Short-term investments18.2B13.8B33.7B34.2B29.6B34.3B983.7M36.4M2.43B640.9M
Receivables37.2B29.3B26.5B22.1B24.7B33.9B15.9B14.5B12.9B14.3B
Inventory42.1B38.8B31.6B30.8B33.4B24.1B14.7B15.2B12.2B9.42B
Current assets122.6B135.8B138.7B117.3B131.1B121.4B57.7B62.8B59.3B41.6B
Property, plant and equipment61.9B56.4B58.2B45.4B30.8B31.4B28.8B27.7B25.4B
Goodwill316.3M316.3M316.3M316.3M316.3M316.3M2.50B2.50B9.08B14.2B
Total assets281.6B254.7B227.9B195.7B192.2B163.5B101.3B103.4B108.2B90.8B
Accounts payable5.41B5.46B5.24B1.58B6.42B6.15B1.32B1.61B3.49B4.06B
Current liabilities23.4B27.4B27.3B16.1B27.1B33.3B17.2B14.7B22.1B11.7B
Long-term debt11.3B1.83B2.10B2.30B1.60B2.80B4.08B19.1B14.2B0
Total debt8.92B6.41B24.4B28.4B
Total liabilities37.5B31.6B30.5B32.1B41.2B43.6B27.7B38.1B40.3B15.6B
Shareholders' equity231.3B210.3B186.2B163.6B151.1B119.9B73.5B65.3B67.9B75.2B
Shares outstanding21.7M22.0M22.0M22.0M22.6M23.0M22.9M23.1M23.0M23.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations22.1B24.9B34.3B23.1B49.9B44.6B17.2B5.31B886.7M11.8B
Capital spending-34.0B-12.5B-5.63B-15.3B-18.2B-4.08B-4.71B-3.59B-5.98B-9.83B
Free cash flow-11.9B12.4B28.7B6.16B31.5B40.4B12.5B1.73B-5.10B1.96B
Cash from investing-12.0B-16.1B-24.5B-15.6B-39.9B-852.1M2.00B-14.4B-16.6B
Cash from financing-7.98B-1.94B-10.2B-19.9B-4.11B-18.7B-4.07B23.1B1.41B
Dividends paid-3.27B-4.40B-3.30B-4.27B-4.61B-1.15B-1.16B-1.15B-2.09B-2.36B
Share buybacks-4.98B-2.83B12.3M-7.08B-8.73B1.50B-2.74B1.49B855.8M2.15B
Change in cash-28.4B5.45B16.2B-12.6B14.8B225.0M-2.22B3.27B9.74B-3.36B